| Source NDC Code |
|
Target HCPCS Code |
72572-0100-01
DAPTOMYCIN LYOPHILIZED 350 MG
|
⇄
|
J0873
INJECTION, DAPTOMYCIN (XELLIA), NOT THERAPEUTICALLY EQUIVALENT TO J0878 OR J0872, 1 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
72572-0100-01
DAPTOMYCIN (PF,LYOPHILIZED) 350 MG
|
⇄
|
J0878
INJECTION, DAPTOMYCIN, 1 MG
|
| Detail Information |
| Relationship Start Date |
09/20/2019 |
| Relationship End Date |
12/31/2023 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
VL |
| Route Of Administration |
IV |
| Billing Units |
EA |
|
|
|
72572-0100-01
Daptomycin
|
⇄
|
J0873
Inj daptomycin (xellia)
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|